Jump to content

Hyperaldosteronism

From Surgopaedia

The unregulated release of excess aldosterone from one or both adrenal glands

Epidemiology

[edit | edit source]
  • Believed to affect about 1-7% of patients with HTN
  • Mean age at diagnosis 50yo
  • Slight male predilection

Aetiology

[edit | edit source]
  • Primary hyperaldosteronism:
    • Autonomous overproduction of aldosterone by the adrenal glands, and not suppressed by sodium loading.
      • Unilateral aldosterone-producing adenomas (most common)
      • Bilateral adrenal hyperplasia (aka 'idiopathic hyperaldosteronism')
      • Familial hyperaldosteronism


Presentation

[edit | edit source]
  • HTN - often moderate-to-severe that is refractory to medical therapy
    • Responsiveness to spironolactone is a good prognostic factor for surgery
  • Most patients are otherwise asymptomatic
    • Hypokalaemia (found in less than 40% of patients with primary aldosteronism - likely severe or late-stage disease)
    • Can be a/w cardiovascular disease, including LVH, AF, MI, CVA
      • These may regress with cure
    • Classically, Conn's syndrome - HTN, polyuria-polydipsia, and hypokalaemia

Workup indications:

[edit | edit source]
  • HTN and spontaneous, or low-dose diuretic-induced, hypokalaemia
  • Severe HTN or drug-resistant HTN (on three-drug program including adrenergic inhibitor, vasodilator and diuretic)
  • HTN with adrenal incidentaloma
  • HTN with OSA
  • HTN and family history of early-onset HTN or CVA<40yo
  • HTN and first-degree relative of patient with primary hyperaldosteronism
  • HTN and AF

Workup:

[edit | edit source]
  • Initial testing:
    • Establish ratio of plasma aldosterone to renin
      • Discontinue spironolactone, ACE inhibitors, diuretics and beta-blockers beforehand
      • Common normal range cut-off of >30:1 gives a sensitivity of 90%. Using a cut-off of >20:1 instead increases sensitivity at cost of specificity; this reflects appreciation of the clinical gravity of missing surgically correctable hyperaldosteronism.
      • Also good to require absolute aldosterone concentration >15mg/dL, since otherwise some patients with fairly normal aldosterone but low renin would meet criteria
      • Plasma renin activity or plasma renin concentration reduced (typically undetectable)
      • Plasma aldosterone concentration is inappropriately high for renin
  • Confirmatory testing:
    • Confirm that high aldosterone levels are non-suppressible with either IV sodium loading (2-3L of isotonic saline over 4-6 hours, followed by measurement of plasma aldosterone) or oral salt loading (5g sodium daily for three days, followed by measurement of 24-hour aldosterone excretion)
  • Localisation
    • CT - differentiate between adrenal hyperplasia and adenoma
      • Adenomas are typically <2cm, aldosterone-producing carcinomas are almost always >4cm
      • Thin-cut (3mm) adrenal CT
    • Adrenal vein sampling
      • Indications
        • Strong indication: Normal CT or bilateral abnormalities
        • Weak indication: When there is a higher chance that the identified lesion is a unilateral non-functioning cortical adenoma, and you may be missing a contralateral micro-aldosteronoma or bilateral adrenal hyperplasia
          • Some say patients >40yo with primary hyperaldosteronism
          • Some say all patients with primary hyperaldosteronism
      • Simultaneous measurement of cortisol and aldosterone levels in the peripheral circulation and left and right adrenal veins
      • Lateralisation is indicated by a four-fold ratio between sides
  • Genetic screening for patients that test positive at <30yo for familial hyperaldosteronism type I, especially if they have a family history of early-onset HTN


Surgery

[edit | edit source]
  • Indications
    • Unilateral disease, either adenoma or hyperplasia, which is causing primary aldosteronism
  • Approach
    • See separate topic under 'operations'
  • Cure metrics
    • Complete - normal BP (less likely in patients that have underlying essential HTN)
    • Partial - decrease in antihypertensive medication
    • Absent
  • Post-op
    • Stop all antihypertensive medications immediately post-op, with the exception of beta-blockers and clonidine to avoid rebound. Add back in as needed.
    • Hyperaldosteronism can mask the true degree of CKD due to glomerular hyperfiltration
    • Hyperkalaemia, related to renal function, occurs 1-3 weeks post-op - monitor with weekly UEC. Persistent hyperkalaemia can be treated with mineralocorticoid replacement (fludrocortisone).


Medical treatment

[edit | edit source]
  • Those unfit for surgery can be treated with mineralocorticoid receptor antagonists (spironolactone or eplerenone)